1-6 of 6
Authors: Casper Hammarstrand
Sort by
Journal Article
MCM7 as a marker of postsurgical progression in non-functioning pituitary adenomas
Get access
Tobias Hallén and others
European Journal of Endocrinology, Volume 184, Issue 4, Apr 2021, Pages 521–531, https://doi.org/10.1530/EJE-20-1086
Published: 01 April 2021
Journal Article
Diagnosing metabolic syndrome in craniopharyngioma patients: body composition versus BMI
Get access
Selvetta S van Santen and others
European Journal of Endocrinology, Volume 181, Issue 2, Aug 2019, Pages 173–183, https://doi.org/10.1530/EJE-19-0181
Published: 01 August 2019
Journal Article
Comorbidities in patients with non-functioning pituitary adenoma: influence of long-term growth hormone replacement
Get access
Casper Hammarstrand and others
European Journal of Endocrinology, Volume 179, Issue 4, Oct 2018, Pages 229–237, https://doi.org/10.1530/EJE-18-0370
Published: 01 October 2018
Journal Article
Excess morbidity and mortality in patients with craniopharyngioma: a hospital-based retrospective cohort study
Get access
Mark Wijnen and others
European Journal of Endocrinology, Volume 178, Issue 1, Jan 2018, Pages 93–102, https://doi.org/10.1530/EJE-17-0707
Published: 01 January 2018
Journal Article
The metabolic syndrome and its components in 178 patients treated for craniopharyngioma after 16 years of follow-up
Get access
Mark Wijnen and others
European Journal of Endocrinology, Volume 178, Issue 1, Jan 2018, Pages 11–22, https://doi.org/10.1530/EJE-17-0387
Published: 01 January 2018
Journal Article
Higher glucocorticoid replacement doses are associated with increased mortality in patients with pituitary adenoma
Get access
Casper Hammarstrand and others
European Journal of Endocrinology, Volume 177, Issue 3, Sep 2017, Pages 251–256, https://doi.org/10.1530/EJE-17-0340
Published: 01 September 2017
Advertisement intended for healthcare professionals
Advertisement intended for healthcare professionals